184 related articles for article (PubMed ID: 36071875)
1. Identification and Validation of Two Heterogeneous Molecular Subtypes and a Prognosis Predictive Model for Hepatocellular Carcinoma Based on Pyroptosis.
Lai M; Liu Q; Chen W; Qi X; Yang J; Jiang L; Yuan M; Liu Z; He Q; Cao J; Yang B
Oxid Med Cell Longev; 2022; 2022():8346816. PubMed ID: 36071875
[TBL] [Abstract][Full Text] [Related]
2. An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis.
Wang H; Wang N; Tang Z; Liu Q; Nie S; Tao W
Hereditas; 2023 Jul; 160(1):30. PubMed ID: 37464443
[TBL] [Abstract][Full Text] [Related]
3. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
[TBL] [Abstract][Full Text] [Related]
4. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R
Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387
[TBL] [Abstract][Full Text] [Related]
5. A novel pyroptosis risk model composed of NLRP6 effectively predicts the prognosis of hepatocellular carcinoma patients.
Gao X; Wang WX; Zhang XL
Cancer Med; 2023 Jan; 12(1):808-823. PubMed ID: 35651286
[TBL] [Abstract][Full Text] [Related]
6. Signature Construction and Molecular Subtype Identification Based on Pyroptosis-Related Genes for Better Prediction of Prognosis in Hepatocellular Carcinoma.
Chen J; Tao Q; Lang Z; Gao Y; Jin Y; Li X; Wang Y; Zhang Y; Yu S; Lv B; Yu Z; Lin C
Oxid Med Cell Longev; 2022; 2022():4494713. PubMed ID: 35069975
[TBL] [Abstract][Full Text] [Related]
7. Identification of the Pyroptosis-Related Prognosis Gene Signature and Immune Infiltration in Hepatocellular Carcinoma.
Yu H; Bai X; Zheng W
Dis Markers; 2022; 2022():9124216. PubMed ID: 35535333
[TBL] [Abstract][Full Text] [Related]
8. A novel risk score model based on pyroptosis-related genes for predicting survival and immunogenic landscape in hepatocellular carcinoma.
Wang H; Zhang B; Shang Y; Chen F; Fan Y; Tan K
Aging (Albany NY); 2023 Feb; 15(5):1412-1444. PubMed ID: 36920176
[TBL] [Abstract][Full Text] [Related]
9. Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes.
Duan S; Gao J; Lou W; Zhang Y; Deng Y; Wang C; Huang H; Xu H; Guo S; Lai S; Xi F; Li Z; Deng L; Zhong Y
BMC Med Genomics; 2022 Jul; 15(1):166. PubMed ID: 35902905
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic values of pyroptosis-related genes for the hepatocellular carcinoma.
Xing M; Li J
BMC Bioinformatics; 2022 May; 23(1):177. PubMed ID: 35562678
[TBL] [Abstract][Full Text] [Related]
11. Construction and validation of a prognostic model of pyroptosis related genes in hepatocellular carcinoma.
Li G; Zhang D; Liang C; Liang C; Wu J
Front Oncol; 2022; 12():1021775. PubMed ID: 36338707
[TBL] [Abstract][Full Text] [Related]
12. A Pyroptosis-Based Prognostic Model for Immune Microenvironment Estimation of Hepatocellular Carcinoma.
Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Jin H; Shi N
Dis Markers; 2022; 2022():8109771. PubMed ID: 35047095
[TBL] [Abstract][Full Text] [Related]
13. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.
Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A
Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200
[TBL] [Abstract][Full Text] [Related]
14. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
Xu L; Zheng Q; Liu W
BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a novel pyroptosis-related lncRNAs signature associated with prognosis and immune regulation of hepatocellular carcinoma.
Zhang Z; Xia F; Xu Z; Peng J; Kang F; Li J; Zhang W; Hong Q
Sci Rep; 2022 May; 12(1):8886. PubMed ID: 35614201
[TBL] [Abstract][Full Text] [Related]
16. Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature.
Zhang Z; Shang J; Hu B; Shi H; Cao Y; Li J; Jiao T; Zhang W; Lu S
Front Immunol; 2022; 13():836576. PubMed ID: 35812396
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
Fu XW; Song CQ
Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
[No Abstract] [Full Text] [Related]
18. Comprehensive Analysis of the Correlation Between Pyroptosis-Related LncRNAs and Tumor Microenvironment, Prognosis, and Immune Infiltration in Hepatocellular Carcinoma.
Qu G; Wang D; Xu W; Guo W
Front Genet; 2022; 13():867627. PubMed ID: 35559014
[No Abstract] [Full Text] [Related]
19. Four-Pyroptosis Gene-Based Nomogram as a Novel Strategy for Predicting the Effect of Immunotherapy in Hepatocellular Carcinoma.
Li N; Ren SH; Qin YF; Shao B; Qin H; Wang Z; Wang HD; Li GM; Zhu YL; Sun CL; Zhang JY; Shi GG; An XW; Wang H
Biomed Res Int; 2022; 2022():2680110. PubMed ID: 35782053
[TBL] [Abstract][Full Text] [Related]
20. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
